Fermenta Biotech's FY25 Revenues Surge by 39% to INR 481.3 Cr, Net Profit INR 76.4 Cr

Fermenta Biotech Limited, a leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals, announced its financial results for the year ended March 31, 2025. The company reported a significant increase in its consolidated revenue, which stood at INR 481.3 crore, up by INR 134 crore YoY. The net profit for the year was INR 76.4 crore, a significant improvement from the year-ago loss. The company's human nutrition volume grew by 48% over FY24 and animal nutrition volume grew by 24% over FY24. Fermenta also successfully completed validation batches for its spray dried variant of Vitamin D3 100,000 IU/g powder for human nutrition and started the qualification process with leading global customers and regulatory authorities.